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a b s t r a c t
WNT signaling is critical in most aspects of skeletal development and homeostasis, and antagonists of
WNT signaling are emerging as key regulatory proteins with great promise as therapeutic agents for bone
disorders. Here we show that Sost and its paralog Sostdc1 emerged through ancestral genome duplication
and their expression patterns have diverged to delineate non-overlapping domains in most organ
systems including musculoskeletal, cardiovascular, nervous, digestive, reproductive and respiratory. In
the developing limb, Sost and Sostdc1 display dynamic expression patterns with Sost being restricted to
the distal ectoderm and Sostdc1 to the proximal ectoderm and the mesenchyme. While Sostdc1 / mice
lack any obvious limb or skeletal defects, Sost / mice recapitulate the hand defects described for
Sclerosteosis patients. However, elevated WNT signaling in Sost /; Sostdc1 / mice causes misregula-
tion of SHH signaling, ectopic activation of Sox9 in the digit 1 ﬁeld and preaxial polydactyly in a Gli1- and
Gli3-dependent manner. In addition, we show that the syndactyly documented in Sclerosteosis is present
in both Sost / and Sost /; Sostdc1 / mice, and is driven by misregulation of Fgf8 in the AER, a region
lacking Sost and Sostdc1 expression. This study highlights the complexity of WNT signaling in skeletal
biology and disease and emphasizes how redundant mechanism and non-cell autonomous effects can
synergize to unveil new intricate phenotypes caused by elevated WNT signaling.
& 2013 The Authors. Published by Elsevier Inc.
Introduction
Gene duplication is at the center of evolutionary diversiﬁcation
and represents a dominant contributor to biological innovation. The
process of gene duplication is the main mechanism by which
paralogous genes with redundant functions emerge, and represents
a means of protecting an organism against deleterious mutations
(Hoffmann et al., 2010; Moleirinho et al., 2011). At the same time,
genes that are not critical (where a critical gene is described by a
lethal embryonic phenotype) are more likely to evolve under less
stringent selective pressure, and in the case of duplicated genes,
maintain some partial functional redundancy. The gene encoding
Sclerostin or Sost is located on human chromosome 17 and its
protein sequence was found to be 55% similar to a homologous
gene, Sostdc1, located on chromosome 7 (Fig. 1). In humans and
mouse models Sost deﬁciency causes Sclerosteosis, a rare autosomal
recessive disorder, characterized by generalized hyperostosis of the
axial and appendicular skeleton (Balemans et al., 2001; Collette
et al., 2012). Due to its highly specialized null phenotype, and
abundant transcription in bone, primarily osteocyte-derived, scler-
ostin was originally described as a protein exclusively secreted by
osteocytes that functions as a negative regulator of bone formation
(van Bezooijen et al., 2005; Winkler et al., 2003), through antag-
onizing the BMP signaling pathway; later was found to also bind to
LRP5/6 co-receptors and antagonize WNT signaling (Kusu et al.,
2003; Li et al., 2005; Semenov et al., 2005; ten Dijke et al., 2008;
van Bezooijen et al., 2007b; Winkler et al., 2003).
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Similar to Sost, its paralog Sostdc1 (Sost domain-containing
protein 1; aka Sostl, USAG-1, Wise, ectodin) has been described as a
WNT antagonist (Ahn et al., 2010), as well as an inhibitor of BMP
signaling (Lintern et al., 2009; Murashima-Suginami et al., 2008).
SOSTDC1 has been shown to be expressed in the kidney (Blish
et al., 2010; Turk et al., 2009), lung (Zhang et al., 2012), the
developing tooth bud of ferrets (Jarvinen et al., 2009), and SNPs in
SOSTDC1 have been associated with a low bone-mass phenotype in
Chinese women, consistent with a possible role in maintaining
functions of the musculoskeletal system (He et al., 2011). Sostdc1-
deﬁcient mice display severe teeth defects characterized by
enlarged enamel knots, altered cusp patterns, fused molars, and
extra teeth (supernumerary incisors) (Kassai et al., 2005; Munne
et al., 2009). In addition, Sostdc1 has been shown to be highly
expressed in distal convoluted tubules and connecting tubules in
the kidney (Tanaka et al., 2008) and Sostdc1-deﬁcient mice were
shown to be resistant to tubular injury in an acute renal failure and
interstitial ﬁbrosis rodent model, revealing that Sostdc1 may
inﬂuence the progression of kidney disease (Yanagita et al.,
2006). Although Sost and Sostdc1 have been studied primarily
from the perspectives of bone mass and kidney response to injury,
respectively, here we show that these genes are broadly expressed
in the mouse during development and adulthood, and we dissect
their shared roles during limb development.
We have recently shown that in addition to functioning as a
WNT antagonist in the adult bone, Sost also plays a critical role as a
negative regulator of WNT signaling in the developing limb. A less
common human phenotype described for sclerosteosis patients is
the occasional presence of hand defects at birth. These abnorm-
alities are primarily characterized by syndactyly [asymmetric
cutaneous or bony syndactyly of the index and middle ﬁngers
(digits 2 and 3)] and radial deviation of the digits, with hypoplasia
and nail dysplasia (symmetric or asymmetric; most commonly
associated with the index ﬁnger) (Hamersma et al., 2003; Itin
et al., 2001; Sugiura and Yasuhara, 1975).
Moreover, using a genetic approach we have previously
demonstrated that over-expression of human SOST from a bacter-
ial artiﬁcial chromosome (BAC) perturbs anterior–posterior and
proximal–distal patterning of the developing limb. These trans-
genic mice showed a wide range of limb defects including fused,
split, missing bones and whole digits and the severity of the limb
defects were shown to be dose-dependent. We also showed that
Sost-deﬁciency rescued signiﬁcant aspects of the Lrp6 / skeletal
phenotypes supporting the view that SOST gain-of-function
impairs limb patterning by inhibiting WNT signaling through the
LRP5/6 co-receptors (Collette et al., 2010).
Because of the evolutionary relationship between Sost and
Sostdc1 as well as their common molecular roles as WNT-, and
possibly BMP- antagonists, we have examined the shared and
unique functions of these paralogs, in single and double knockout
mice. Initially, we describe in detail, both the embryonic and adult
tissue distribution of these transcripts through the use of LacZ-
knock-in alleles. We ﬁnd both genes to have dynamic and complex
expression patterns during embryonic and limb development, and
are often expressed in adjacent tissues or cell types. In the adult
mouse, we ﬁnd Sostdc1 to be more widely distributed than Sost;
however signiﬁcant expression of Sost was detected in non-
skeletal tissues. In general, when these genes are expressed in
the same organ system, they are present in non-overlapping
expression domains, suggesting that these genes have evolved
different sub-specializations within the signaling pathways they
regulate, as a function of their cellular location.
In particular, we focused our analysis on the characterization of
their shared roles during limb development. Herein, we show that
Sost deﬁcient mice recapitulate the hand defects described for
sclerosteosis patients (Itin et al., 2001), at a frequency of 4%, while
Sostdc1 / lack any skeletal patterning defects; they do display
mild ventralization characterized by pigmentation and hair
growth on the ventral side of the autopod. We also ﬁnd that
consistent with their site of gene expression in the developing
Fig. 1. Sost–Sostdc1 evolutionary relationship. An overview of SOSTDC1 (left) and SOST (right) evolution, created by tracking the SOSTDC1 and SOST gene loci through
representative vertebrate genomes (not to scale) from (A) Euteleostomi, (B) Tetrapoda and (C) Mammals clades. Predicted orthologs (where annotation is not available) are
shownwith gray dotted lines. Genes are shown as arrowheads, with their gene symbols above. Genes that are not conserved/likely to be poorly annotated are represented in
white. The direction of the arrowhead indicates the relative transcriptional orientation and the relevant genome coordinates indicated on the left and right respectively.
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limb, Sost /; Sostdc1 / mice exhibit preaxial polydactyly,
detected visually as early as E11.5, indicating that Sost and Sostdc1
play partially redundant and complementary roles in the devel-
oping limb. Through a combination of in situ marker and micro-
array gene expression analysis we show that the combined
absence of Sost and Sostdc1 interferes with components of WNT,
BMP, SHH, FGF and TGFb signaling to produce several limb
abnormalities that include: preaxial polydactyly, syndactyly, dor-
salization, radial deviation and nail dysplasia. In particular we
show that the preaxial polydactyly is driven by misregulation of
SHH signaling, where the Shh and Gli1 expression domains are
elevated and expanded anteriorly, while Gli3 expression levels are
reduced. Grem1 expression is missing in the anterior mesenchyme
of the limb bud where the duplicated digits form, and Hoxd13 is
ectopically expressed. We conclude that Sox9 ectopic activation in
the digit 1 ﬁeld is promoted by the misexpression of Gli1
transcription factor, which has been previously shown to control
Sox9 transcription, and by the lack of Gli3-dependent gene
repression. We also examined the underlying causes of the
observed syndactyly, and found Fgf8 levels to be elevated, and
BMP4 and BMP7 to be absent in the AER; the Fgf8 AER expression
domain is expanded proximally and disorganized which resulted
in a reduction in interdigital apoptosis in regions corresponding to
the observed syndactyly. Thus, the absence of Sost and Sostdc1 in
the limb disrupts the epithelial–mesenchymal communication
required for proper limb patterning in these compound mutants,
in vivo.
Materials and methods
Mouse strains and embryos
Sost / and Sostdc1 / mice were generated by replacing the
open reading frame with the LacZ reporter as previously described
(Collette et al., 2010; Tanaka et al., 2010). Sost /; Sostdc1 / were
generated by mating Sost / and Sostdc1 / mice; E9.5 to E17.5
embryos were collected at various embryonic stages and geno-
typed by PCR. E0.5 of gestation was considered to be noon on the
day a copulatory plug was observed. Embryos earlier than E12.0
were stage-conﬁrmed by somite counting for all subsequent
analyses. All animal experiments were carried out in PHS-
assured facilities in accordance with guidelines set by the Animal
Care and Use Committee at University of California-Berkeley and
Lawrence Livermore National Laboratory.
Identiﬁcation of orthology and paralogy relationships
Human, rat, mouse, cow, chicken, and zebraﬁsh orthologs of
SOSTDC1 and SOST were identiﬁed from the Homologene database
(Sayers et al., 2012) Release 66. HomoloGene homology searches
rely on both proteins and their corresponding DNA sequences
alignments, as well as synteny information, when applicable, and
have been shown to perform well in phylogenetic and functional
analyses where high speciﬁcity is required (Altenhoff and
Dessimoz, 2009). In the case of frog, which is not included in the
Homologene database, we used tBLASTn and BLASTp with the
human protein sequences of SOSTDC1 and SOST to search the
nucleotide and protein databases in NCBI, respectively; we only
considered sequences represented in the current RefSeq (Pruitt
et al., 2012).
Whole-mount in situ hybridization
Whole-mount in situ hybridizations were carried out using stan-
dard procedures (Collette et al., 2010). Brieﬂy, digoxigenin-labeled
antisense RNA probes were generated to the desired RNA sequence
and hybridized to whole-mount embryos. Expression was visualized
by binding BM Purple (Roche) to an alkaline-phosphatase conjugated
anti-Digoxigenin antibody (Roche). Antisense RNA probes for Grem1
(MluI-SacII fragment of NM_011824), Fgf8 (PstI 3′cDNA and UTR
fragment of NM_010205); (Crossley and Martin, 1995), Shh (MscI-NarI
fragment of NM_009170); (Echelard et al., 1993) were generated as
described (Hogan et al., 1994) with the following modiﬁcation:
proteinase K digestion was omitted for ectodermal or AER probes.
Gli1 (NM_010296.2) probes were generated from gel-puriﬁed PCR
fragments (Gli1 5′-TCCTCCTCTCATTCCACAGG-3′; 5′-TCCAGCTGAGTGT
TGTCCAG-3′). A minimum of 4 embryos were used per genotype, per
experiment.
LacZ stains
Embryos were dissected into ice-cold 1 phosphate-buffered
saline (PBS), pH 7.3 and ﬁxed in 2% paraformaldehyde, 0.2%
glutaraldehyde in 1 PBS, 2 mM MgCl2 at 4 1C for 30 min to 1 h,
followed by extensive rinsing in 1 PBS, 2 mM MgCl2. Embryos
were stained overnight at 4 1C in X-gal stain: 1 mg/ml X-gal,
MgCl2, 5 mM EGTA, 0.02% Nonidet P-40, 5 mM potassium ferro-
cyanide, 5 mM potassium ferricyanide, in 1 PBS, pH 7.3. Neo-
nates and adults (6 months of age) were skinned, eviscerated, and
ﬁxed as whole animals in 4% Paraformaldehyde in 1X PBS, 2 mM
MgCl2 for 1 h at 4 1C followed by extensive rinsing and staining
overnight (neonates) or 48 h (adults) at 4 1C in LacZ staining
solution, as for embryos. Prior to staining, adult bones were
decalciﬁed in 0.5 M EDTA, pH 7.3, by the weight loss-weight-
gain method of decalciﬁcation endpoint determination. After
staining, embryos were post-ﬁxed in 4% paraformaldehyde in
1 PBS, pH 7.3 at 4 1C, and then cleared in glycerol for photo-
graphy. For sectioning, neonate and adult tissues were post-ﬁxed
for 72 h in 4% paraformaldehyde, dehydrated and embedded into
parafﬁn wax. Section were cut at 6 mm, baked at 42 1C overnight,
counterstained with Nuclear Fast Red and mounted with Per-
mount for imaging.
Skeletal preparations
Skeletal preparations were carried out on neonate and adult
mice (6 months of age) using Alcian Blue 8GX for cartilage and
Alizarin Red S for bone as previously described (Collette et al.,
2010); E12.5–E14.5 mouse embryos were stained with Alcian Blue
8GX for cartilage only (0.05% in 4% glacial acetic acid).
Lysotracker apoptosis stain
Embryos were dissected at E12.5 and E13.5 in Hank's balanced
saline solution (HBSS) and placed in lysotracker staining solution
(2.5 ml/ml in HBSS) for 30 min at 37 1C. Embryos were washed
with 1 PBS (pH 7.3) 2 and ﬁxed overnight in 4% paraformal-
dehyde at 4 1C and dehydrated in methanol and cleared in benzyl
alcohol:benzyl benzonate (1:1) for photography.
Immunoﬂuorescent antibody stain
Embryos were dissected at E12.5 into ice-cold PBS and ﬁxed for
24 h in 4% paraformaldehyde at 4 1C. Embryos were washed, dehy-
drated, and embedded into parafﬁn for sectioning. Slides were de-
waxed and epitopes requiring antigen retrieval were incubated in
Uni-Trieve (Innovex) for 30 min at 65 1C unless otherwise indi-
cated. Slides were blocked with 5% BSA/0.01% Triton X-100 (Sigma)
or Rodent Block (Innovex, for mouse/rat monoclonal antibodies
only), incubated in a humid chamber with primary antibody
overnight at room temperature [1:200, anti-Gli3 (abcam), 1:200,
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anti-activated beta-catenin clone 8E7 (Millipore)], washed, and
incubated for 2 h with Alexa-ﬂuor-labeled secondary antibody
(1:1000, Invitrogen/Molecular Probes), washed, and mounted
using Prolong Gold/Prolog Gold with DAPI (Invitrogen/Molecular
Probes) for imaging. Images were acquired using single-channel
ﬂuorescent ﬁlters on a Leica DM5000 compound microscope using
a Qimaging color CCD camera and ImagePro software. Goat
polyclonal anti-Sclerostin antibody (1:200, R&D Systems, cat#
AF1589) and anti-goat Alexa-Fluor 488 secondary antibody
(1:1000, Molecular Probes, cat# A21467) were used to determine
Sost localization on bone parafﬁn sections as previously described
(Collette et al., 2012).
Microarray analysis
Microarray data analysis was performed using R programming
platform and Bioconductor (Gentleman et al., 2004). Bioconductor
package ‘affy’ (Gautier et al., 2004) was used for data quality
assessment. Data preprocessing and normalization were performed
using Robust Multi-chip Average (RMA) protocol (Irizarry et al.,
2003). Differentially expressed genes were identiﬁed using the
empirical Bayes method implemented in Linear Models for Micro-
Array (LIMMA) (Smyth, 2004) package. Probes were mapped to
genes using Affymetrix Mouse Genome 430 2.0 Array annotation
data from Bioconductor annotation package ‘mouse4302.db’. Fold
change values were calculated as the ratio between the averages of
normalized intensities of the two groups, Sost /; Sostdc1 / and
wildtype. Fold change values for differentially expressed genes are
reported in a log2 scale. Genes with fold change of 2 (log2 FC¼1) or
greater and P-value less than 0.05 were considered differentially
expressed. Pathway enrichment analysis was performed using the
Database for Annotation, Visualization and Integrated Discovery
(DAVID) (Dennis et al., 2003; Huang da et al., 2009) and Kyoto
Encyclopedia of Genes and Genomes (KEGG) option (Kanehisa et al.,
2010). Pathways with EASE score, a modiﬁed Fisher Exact p-value
less than 0.1 were considered as enriched. Microarray data is
publicly available at NCBI (GS E44325).
Results
Sost and Sostdc1 arose as duplication/divergence events
The human genomic region containing SOSTDC1 protein on chr
7 is syntenic with the region containing SOST on chr 17 (Fig. 1).
Both SOSTDC1 and SOST genes are extremely well conserved in the
descendants of the ancestral Euteleostomi. Earlier chordates show
some evidence of a SOSTDC1 or SOST ortholog, suggesting that the
duplication event took place at least 500 million years ago and
that the genes belong to an ancient gene family. Other genes that
are neighbors of SOSTDC1 also have paralogs in the neighborhood
of its paralog SOST, and this is true in all analyzed genomes. Thus,
ETV1 and MEOX2 are paralogs of ETV4 and MEOX1, respectively.
This situation is consistent with a large-scale, possibly genomic
duplication event, such as those that took place in the vertebrate
ancestor (Dehal and Boore, 2005). The duplication was followed by
divergence, resulting in the present-day human SOSTDC1 and
SOST sharing only 40–42% of their amino acids, with similarity
spanning over 84–92% of the protein lengths. It is likely that
additional paralogous genes in these syntenic regions have
diverged beyond our ability to detect homology. Individually, each
of the corresponding syntenic regions, including other genes
and their relative order, is remarkably well conserved in Euteleos-
tomi, suggesting ﬁxation of the duplicated genes after a period of
rapid divergence. Only in one examined lineage, the amphibians
represented by X. tropicalis, we ﬁnd Sost to be absent, suggesting
that the duplicated region has been lost in this lineage. Finally, the
noncoding regions in the vicinity of SOSTDC1 and SOST are not
uniformly conserved; while SOSTDC1 is surrounded by a high
density of evolutionary conserved noncoding sequences in mam-
mals, only a few of these elements are shared among amniotes,
suggesting neo- or sub-functionalization of the gene; in contrast
some noncoding elements in the vicinity of SOST are conserved not
only among amniotes, but, to a less extent, in tetrapods and ﬁsh
(Loots and Ovcharenko, 2007).
Sost and Sostdc1 have non-overlapping expression patterns during
limb development
LacZ was used to determine Sost and Sostdc1 expression in Sost-
LacZ knock-in mice (referred to as SostLacZ for expression analysis,
Sost / for phenotype analysis) and Sostdc1-LacZ knock-in (referred
to as Sostdc1LacZ for expression analysis, Sostdc1 / for phenotype
analysis). SostLacZ was observed as early as E9.5 in the distal limb
bud (Fig. 2A–A″). This expression is restricted to the ectoderm and is
excluded from the apical ectodermal ridge (AER) and mesenchyme
at all time points examined (Fig. 2A–F and b–d). Sostdc1LacZ emerges
ectodermally at E10.5 in a small ﬁeld on the posterior side of the
limb near the zone of polarizing activity (ZPA) marked by sonic
hedgehog (Shh) (Fig. 2h, corresponding Shh expression indicated in
Fig. 6A). By E11.5 its expression is strongly present primarily in the
mesenchyme of the proximal limb (Fig. 2I and i). By E12.5 Sostdc1
expression activated in the cartilage template outlining the ribs,
vertebrae and digits (Fig. 2J and j). As limb development progresses,
SostLacZ remains conﬁned to the ectoderm, and by E14.5 its expres-
sion becomes fainter and restricted to the digits. In contrast,
Sostdc1LacZ expands its expression domain, surrounding the con-
densing cartilage anlagen, and intensifying in the proximal limb. By
E14.5 Sostdc1 is highly expressed in the limb in regions that include
cartilage templates of the digits, mesenchyme and primary hair
germs that are ectodermal derived, but is omitted from the most
distal tips of the digits.
At E10.5–11.5 both Sost and Sostdc1 are expressed in the head
and mark parts of the nervous system of the developing embryos,
but Sost expression has some unique features. As early as E9.5 Sost
marks a very thin layer of cells that line the edge of the neural
folds (Fig. 2B, C and Sup. Fig. 1A). As the neural folds close, Sost
expression becomes restricted to the base of the cerebellum
(Fig. 2D–E), consistent with our previously results in the adult
cerebellum (Collette et al., 2012). Along the trunk, at E11.5 Sost
emerges symmetrically at the base of the spinal cord, at the level
of the forelimbs (Fig. 2C; Sup. Fig. 1B and D) in a cluster of cells
that likely mark the lateral motor neurons migrating into the limb.
A zoomed in view allows the visualization of projections into the
limb bud that resemble previously described projections of motor
axons (Dasen et al., 2008) (Sup. Fig. 1D); by E13.5 Sost marks a
network of axons that innervate the dorsal limb ﬂank mesench-
yme (Fig. 2E′; Sup. Fig. 1E), and appears near the base of the
hindlimbs by E13.5 (Sup. Fig. 1C). Sostdc1 outlines the branchial
arches as early as E10.5 (Fig. 2H); it marks the otic vesicle (Fig. 2H)
and by E14.5 it is highly expressed in the ear, the developing skin
and hair follicles (Fig. 2L). The E14.5 Sostdc1 ectodermal expression
(Fig. 2L) is similar to the previously reported beta-catenin LacZ
reporter strains (Zhang et al., 2012; Narhi et al., 2008).
Sost and Sostdc1 are expressed in adjacent tissues in the neonatal
skeleton
Starting at E16.5, Sost expression becomes restricted primarily
to the skeleton, while Sostdc1 expression spreads over the ecto-
derm, marks the hair follicles (Laurikkala et al., 2003; Narhi et al.,
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2008), tooth germs (Laurikkala et al., 2003) and many soft tissues
throughout the late embryo. In neonates Sost marks the axial and
appendicular skeleton (Fig. 3A–B), while Sostdc1 is more broadly
expressed in the limb and other soft tissues adjacent to bone
(Fig. 3A′–B′). In the neonatal bone, we ﬁnd Sost expression
primarily in a location consistent with osteocytes (Fig. 3C and c);
no Sostdc1 expression is detected in this cell type; however Sostdc1
is highly expressed in the adjacent periosteum (Fig. 3C′ and c′),
connective tissue, muscle, and periarticular chondrocytes of the
epiphysis (Fig. 3D′), while Sost expression is missing in these tissue
types (Fig. 3D). In the skull and jaw Sostmarks putative osteoblasts
and osteocytes cells in wholemount calvaria (Fig. 3E and e) while
Sostdc1 is found in the membrane covering the calvaria (Fig. 3E′
and e′) and in the connective tissue surrounding the mandible
(Fig. 3F′). Signiﬁcant Sostdc1 expression was also found in the
peripheral nervous system and in intervertebral disks (Fig. 3B′).
Other sites of Sost neonatal expression included speciﬁc regions of
the cardiovascular system (Sup. Fig. 2B, b, C and c). Sostdc1 was
also found in the kidney and in the urogenital system in neonates.
Sostdc1 and Sost have broad tissue distribution in the adult
In adult tissues, Sost and Sostdc1 expression domains compre-
hensively encompass nearly every organ system and tissue in the
body. Sost is robustly expressed in the skeleton, primarily in
osteocytes, but low levels of Sost expression were also detected
in osteoblasts and osteoclasts (Sup. Fig. 3A and C). This expression
is consistent with its previously described roles in bone formation
(Collette et al., 2012; Li et al., 2008), B-cell maintenance in the
bone marrow niche (Cain et al., 2012), as well as recent reports
that Sost is expressed in osteoclasts of aged mice (Ota et al., 2013).
Other sites of Sost expression included the epididymis and vas
deferens of the testis (Sup. Fig. 4A and a), the pyloric sphincter
(Sup. Fig. 4B), parts of the cerebellum (Sup. Fig. 4C and c) and the
kidney (Sup. Fig. 4E and e). Contrary to previous reports, Sost
expression was not detected in the liver or cartilage, suggesting
some differences between human and mouse endogenous Sost
expression (Geetha-Loganathan et al., 2010). However, Sost carti-
lage expression has recently been linked to osteoarthritis, and
there is a possibility that Sost expression turns on in the articular
cartilage in response to joint trauma (Chan et al., 2011).
Sost expression was also detected in a highly restricted cluster
of cells in the heart (Sup. Fig. 2D, d, and e), and in the ascending
aorta branches (carotid arteries) of both the neonatal and adult
heart (Sup. Fig. 2B, C, b, c, and E). The cardiovascular neonatal
expression we observed is consistent with previous reports where
Sost expression was detected in the smooth muscle cells of the
ascending aorta, aortic arch, brachiocephalic artery, common
carotids, and pulmonary trunk (van Bezooijen et al., 2007a). In
contrast, Sostdc1 expression was present in the cardiac plexus that
innervates the heart (Sup. Fig. 2F and f).
Sostdc1 expression, however, has not been fully characterized.
Sostdc1 is expressed in the skin and hair follicles (Fig. 4A and a–a′),
in the brain (Fig. 4B and B′), the stomach and intestines (Fig. 4C, C′,
D and D′), pancreas (Fig. 4E and E′), kidney (Fig. 4F and F′), nerves
(Fig. 4G and I), lungs (Fig. 4H), smooth and skeletal muscles (Fig. 4J
and K), vasculature (Fig. 4L), the urogenital system, teeth, con-
nective tissue and periosteum. Previously published reports have
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Fig. 2. Sost and Sostdc1 expression during limb development visualized by LacZ expression. Sost (A–F) and Sostdc1 (G–L) expressions were examined in a time-course panel
of E9.5–E14.5 heterozygous embryos referred to as SostLacZ and Sostdc1LacZ. At E9.5 in SostLacZ embryos, a dorsal view of the whole embryo (A′) and of the forelimb (A″) shows
expression in the emerging limb bud while no limb expression is detected in Sostdc1LacZ (G). For E10.5 to E12.5 embryos (B–D and H–J), AER views (B′–D′), dorsal limb views
(B″–D″ and H′–J′) and transverse section views (b–d; h–j; and i′, j′) are provided. For E13.5 and E14.5 embryos (E–F; K–L), dorsal limb views (E′–F′; K′–L′) are provided.
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described several phenotypes associated with these expression
domains including roles in tooth development (Kassai et al., 2005),
hair follicle development (Narhi et al., 2008, 2012), urogenital
system development (Maeda et al., 2007), kidney development
and toxicity (Tanaka et al., 2008), and more recently pancreas
metabolism (Henley et al., 2012). While Sostdc1 expression has not
been described in the context of muscle tissue, the robust inter-
mittent expression pattern is consistent with a described role for
WNT signaling in the identity of muscle ﬁber types (Tee et al.,
2009; von Maltzahn et al., 2012).
Preaxial polydactyly in Sost /; Sostdc1 / mice
Sostdc1 has not been previously associated with functions
during skeletal development and Sostdc1 / mice do not exhibit
any obvious limb patterning defects. In contrast, Sost has been
described in limb development in the context of Sclerosteosis.
Sclerosteosis patients show variably penetrant limb developmen-
tal anomalies in the autopod, with a range of phenotypes that
include soft and/or bony tissue syndactyly of anterior digits, nail
dysplasia and radial deviation of digits (Hamersma et al., 2003;
Itin et al., 2001). We also recently described SOST gain-of-function
mice where overexpression of SOST caused severe limb patterning
defects (Collette et al., 2010). Upon closer examination of Sost /
mice we found 4% of neonates to display all hand defects
previously described for Sclerosteosis patients (Fig. 5B–B2;
Table 1). In addition, both Sost / and Sostdc1 / mice had
varying degrees of ventral pigmentation and ectopic hair growth
on the autopod (Fig. 5b′; Table 1). When Sost / mice were mated
to Sostdc1 / to generate double knockout mice, 50% of the
double knockout embryos displayed hand defects. Also, a new
autopod defect emerged consisting of preaxial polydactyly pri-
marily of digit 1 and occasionally of digit 2 (Fig. 5C–C″and C4–C4′).
The accompanying syndactyly of anterior digits seen in Scleros-
teosis occurred in 6% of the embryos, but was not statistically
different from the single mutant (Table 1). The preaxial polydac-
tyly was visualized as early as E11.5 of development, in the form of
ectopic tissue thickening in the anterior limb, during digit speci-
ﬁcation and templating of the autopod and is evident as poly-
dactyly by as early as E12.5 (Fig. 5C1, arrow). We observed varying
degrees of duplication, from incomplete soft-tissue duplication, to
duplication of multiple projections with or without bone, at the
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Fig. 3. Sost and Sostdc1 expression in the neonatal skeleton. Sost expression marked cells in the appendicular (A) and axial (B, E) skeleton, while Sostdc1 was more broadly
expressed in the limbs (A′) and rib cage (B′) to encompass connective tissue, muscle, cartilage and neurons. Sectioned long bones revealed Sost expression primarily in the
osteocytes of cortical bone (C and c), but no obvious Sost expression was detected in the articular cartilage (D). Sostdc1 however was not detected in the mineralized bone; it
was expressed in the periosteum (C and c′), the immediately adjacent muscles (C′) and the periarticular chondrocytes in the condyle (D′). Both Sost and Sostdc1 were also
detected in the skull (E and E′) and mandible (F and F′); Sost expression was localized to osteoblasts and osteocytes in wholemount calvaria (e), while Sostdc1 was present in
the connective tissue over the calvarial bones (e′); and m muscle; ocy osteocytes; bm bone marrow; po periosteum; cb cortical bone; gp growth plate; and ch chondrocytes.
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site of the expected ﬁrst digit, and protruding from the ventral
autopod, the majority of defective Sost /; Sostdc1 / adults had
a rudimentary duplicated thumb (Fig. 5C4′ and C4″) or an occa-
sional branching off digit 2 (Fig. 5C4).
Sox9 is expressed in committed chondroprogenitor cells and
differentiated chondrocytes and has been previously shown to
function as an essential regulator of chondrogenesis. When Sox9
was expressed ectopically in Sox9-transgenic mice, the cell density
of the anterior limb bud mesenchyme at the site of Sox9 transgene
expression increased around E13.5, and a nubbin emerged E14.5
highly similar to the ectodermal protrusion observed in Sost /;
Sostdc1 / autopods (Fig. 5C3) (Akiyama et al., 2007). The Sox9
transgenics showed increased proliferation at Sox9 ectopic sites
and the subsequent differentiation of Sox9 positive cells into
chondrocytes (Akiyama et al., 2007). To determine if Sox9 is
involved in the Sost /; Sostdc1 / autopod defect, we examined
Sox9 expression in E13.5 embryos. Expression of Sox9 appeared
reduced in Sost / and enhanced in Sostdc1 / embryos,
although these patterns are not associated with cartilage templat-
ing defects in the single mutants. In Sost /; Sostdc1 / autopods,
ectopic expression of Sox9 was observed in the anterior region
of digit 1 (Fig. 5G) which corresponded to the site of digit 1
duplication.
Changes in Gli1/Gli3 expression promote ectopic Sox9 and
polydactyly in Sost /; Sostdc1 /
Digit 1 formation has been described as Shh-independent since
Shh / mice are missing all but digit 1, however altered morpho-
gen diffusion or ectopic Shh affects anterior digits and has been
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Fig. 4. Sostdc1 expression in adult tissues. Sostdc1 expression was examined in wholemount and sectioned LacZ stained tissues, and was detected in the skin and hair
follicles (A, a, and a′). A highly specialized region in the brain was positive for Sostdc1 (B and B′). Smooth muscles of the stomach (C and C′), intestine (D and D′) and
esophagus (J), and skeletal muscle (K) expressed Sostdc1. Sostdc1 was also robustly expressed in the pancreas (E and E′) and kidney (F and F′) and in the nervous system
Sostdc1 stained spinal ganglia (G) and the lungs (H). Neurons (I) and vasculature was also positive for Sostdc1 (L).
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shown to cause digit duplication. A number of mouse mutants
with preaxial polydactyly exhibit ectopic Shh expression in the
anterior mesenchyme of the limb bud during development; these
include Extra toes (Xt), Strong’s luxoid (lst), luxate, X-linked poly-
dactyly, Rim4, Hemimelic extra toes, as well as Msx1 /;Msx2 /
mutants (Bensoussan-Trigano et al., 2011; Buscher and Ruther,
1998; Chan et al., 1995; Masuya et al., 1995; Sharpe et al., 1999). In
particular paired-type homeodomain transcription factor Alx4 is
expressed in the mesenchyme of the anterior limb, and when
mutated causes preaxial polydactyly slightly more severe than the
polydactyly observed in Sost /; Sostdc1 / mice. Since Sostdc1
expression domain slightly overlaps the ZPA at E10.5 (Fig. 2H′) and
Alx4 as well as Msx1 /;Msx2 / mice display ectopic Shh in the
anterior digit 1 ﬁeld of the autopod, we ﬁrst compared Shh
expression in single and double mutant embryos to WT embryos.
Consistent with loss of Shh expression in SOSTtg limbs (Collette
et al., 2010), the Shh ﬁeld was expanded both anteriorly and
distally in Sost / and Sost /; Sostdc1 / embryos as early as
E10.5 of development; in double mutants, this was before the
preaxial polydactyly was visually detected (Fig. 6A). Shh expres-
sion in E11.5 Sost /; Sostdc1 / limbs was estimated to be 3.66-
fold above WT levels as determined by microarray expression
analysis (Table 2). However, unlike other mutants with digit 1
polydactyly, we detected no ectopic Shh expression in the anterior
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Fig. 5. Limb defects in Sost / and Sost /; Sostdc1 / mice. Compared to adult WT autopods (A), Sost / autopods (B, B1, and B2, insets at b′ and b″) displayed
pigmentation on the ventral side (B1and b′), digit 2–3 syndactyly (B2 and b″; red arrow), nail dysplasia (B, B1 and B2; yellow arrows) and radial deviation of digits, primarily
observed for digit 4 (B, B1 and B2, dotted lines). Ventral pigmentation was also observed in Sost /; Sostdc1 / autopods. Unlike WT and Sost / autopods that had normal
digit patterning (A′–B′), Sost /; Sostdc1 / digit 1 was thicker (C, C″ and c′; asterisk) and skeletal preparation indicated the presence of extra bones (C′) in digit 1. A time
course skeletal preparation examination revealed that an ectopic digit 1 was distinguishable as a tissue projection as early as E12.5 (A1-3 vs. C1-3); and the neonate Sost /;
Sostdc1 / limbs displayed a range of extra digits (C4 and C4″) associated with ectopic projections primarily from digit 1 (C4′ and C4″) and in rare occasions from digit 2 (C4;
black arrow). Sox9 in situ hybridization on E13 embryos revealed an ectopic digit 1 ﬁeld in Sost /; Sostdc1 / autopods. d digit.
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region of the E10.5 or E11.5 autopod (Fig. 6A and D) in all Sostdc1 /
; Sostdc1 / embryos examined (N¼28). Consistent with Shh
expansion, Grem1 domain was reduced posteriorly since Shh
positive cells repress Grem1 expression (Fig. 6B), and was also
missing in the anterior mesenchyme where ectopic digits form in
double mutants (Fig. 7K′ and K″), but this reduction did not
translate into a signiﬁcant quantitative change in Grem1 expres-
sion by microarray analysis in the E11.5 limb (Log FC: 0.81, FC: 1.75,
p-value: 0.37133).
SHH signaling utilizes Gli transcription factors to mediate
anterior–posterior limb patterning, and these proteins can func-
tion as either activators or repressors of transcription. Gli3, which
functions primarily as a repressor, but the full-length protein can
also serve as an activator, has been suggested to be the main
effector of SHH signaling. In the absence of Gli3 repression, anterior
digits are duplicated and take on anterior digit character that is
dependent on the timing of Gli3 inactivation, such that inactiva-
tion at E10.5 causes digit 1 duplication highly similar to the
phenotype observed in Sost /; Sostdc1 / (Bowers et al., 2012).
Gli1, a downstream transcriptional activator of SHH, while not
deemed essential for limb development in single KOs, does
contribute to the formation of a posterior tissue nubbin in Gli1 /;
Gli2 / autopods (Park et al., 2000), and has been shown to
activate Sox9 expression via a Gli1-dependent transcriptional
regulatory element (Bien-Willner et al., 2007). Consistent with
these previous observations, we ﬁnd Gli1 to be up-regulated in
Sost /; Sostdc1 / at E11.5, through both a dramatic anterior
expansion (Fig. 6E) as well as a 2.3-fold change in transcript levels.
Quantitatively Gli3 was reduced by 3.68-fold in Sost /; Sostdc1 /
 in E11.5 limbs (Table 2). Immunoﬂuorescent stains for activated
Gli3 conﬁrmed a dramatic reduction of Gli3 activator in the
ectoderm, mesenchyme and in the cartilage anlangen in the
E12.5 Sost /; Sostdc1 / limbs (Fig. 7D–F). In addition we
observed ectopic anterior Hoxd13 expression (Fig. 7L′–L″) in
E11.5 Sost /; Sostdc1 / limbs consistent with results described
for a hypermorphic activator allele of Gli3 that resulted in preaxial
polydactyly (Wang et al., 2007). Comprehensively, these ﬁndings
suggest that the preaxial polydactyly in Sost /; Sostdc1 / limbs
is the result of altered SHH signaling that induces ectopic Sox9
expression via Gli3 derepression to promote tissue nubbins or
extra rudimentary copies of anterior digits.
Altered FGF and BMP signaling cause syndactyly in Sost /;
Sostdc1 /
Sostdc1 has been previously characterized as both a WNT- and
BMP-antagonist (Henley et al., 2012; Murashima-Suginami et al.,
2008; Tanaka et al., 2008), and ectodermal derived BMPs and Fgf8
have been shown to control interdigital apoptosis (Hernandez-
Martinez et al., 2009), a mechanism involved in the establishment
of both polydactyly and syndactyly. Consistent with previous ﬁnd-
ings that Fgf8 expression promotes cell survival and growth in the
distal limb mesenchyme and that Fgf8 repression triggers interdigital
apoptosis associated with syndactyly we found Sost /; Sostdc1 /
embryos to display both an increase in Fgf8 expression characterized
by disorganized expansion of the AER domain, as well as a disrup-
tion of the AER continuity characterized by speckled down-
regulation of Fgf8 primarily in the anterior region of the limb
(Fig. 6C, F, and G). Quantitatively Fgf8 was found to be 2.43-fold
above WT levels in Sost /; Sostdc1 / E11.5 forelimbs, while Fgf
receptors 1 through 3 were down-regulated (Table 2). Since 6% of
Sost /; Sostdc1 / embryos display syndactyly of anterior digits,
we examined whether regions of Fgf8 down-regulation corre-
sponded to a decrease in interdigital apoptosis, and found a reduc-
tion in apoptosis in the 1-2 interdigital ﬁeld at E12.5 (Fig. 6I).
Since Bmp2/4 restrict Shh expression and antagonize Fgf signaling
in the early limb, and Bmp7 induces cell death in the distal
mesenchyme and inhibits Fgf8 expression in the ectoderm at later
developmental times, we examined whether members of the Bmp
family are transcriptionally affected in Sost /; Sostdc1 / embryos.
In situ hybridization for Bmp4 and Bmp7 showed a complete absence
of expression in the AER of Sost /; Sostdc1 / embryos (Fig. 7M–
N). Additionally, most Bmp-related transcripts were down-regulated
in Sost /; Sostdc1 / E11.5 forelimbs suggesting an overall reduc-
tion in BMP-signaling in the limb (Table 2) which may account
for both Shh up-regulation and Fgf8 ectodermal/mesenchymal
expansion.
WNT signaling is both up- and down-regulated in Sost /;
Sostdc1 / limbs
Sost and Sostdc1 have been previously described as antagonists
of both WNT and BMP signaling (Collette et al., 2010; Holdsworth
et al., 2012; Krause et al., 2010; Tanaka et al., 2010; Winkler et al.,
2003). Our previous work of examining limb defects in transgenic
mice overexpressing SOST showed that the BatGal transgene, a
reporter of canonical WNT signaling was down-regulated in the
limb mesenchyme, in response to elevated levels of SOST in the
limb ectoderm (Collette et al., 2010). This data suggested that SOST
functions as a WNT antagonist in the limb, in gain-of-function
transgenic mice. Based on these previous ﬁndings, we anticipated
Sost /; Sostdc1 / limb buds to display elevated WNT and/or
possibly BMP signaling.
To determine what signaling pathways are altered due to lack of
Sost and Sostdc1 in the limb, we compared gene expression between
Sost /; Sostdc1 / and wildtype E11.5 forelimbs using Affymetrix
gene expression arrays (Mouse Genome 430 2.0 Array). We found
1218 and 1701 transcripts to be more than 2-fold up- or down-
regulated in Sost /; Sostdc1 / forelimbs (pr0.05), respectively.
Consistent with the molecular marker analysis and WNT signaling
function, pathway analysis identiﬁedWNT and SHH signaling among
the top most signiﬁcantly enriched in up-regulated genes; while all
signiﬁcantly altered transcripts associated with the BMP and TGFb
signaling pathways were down-regulated in Sost /; Sostdc1 /
limbs (Table 2). Interestingly, the WNT signaling was also identiﬁed
among the top enriched in down-regulated genes, with 16 tran-
scripts dramatically reduced in Sost /; Sostdc1 / limbs (Table 2).
To further determine what changes in WNT signaling occurred
as a relationship of the signal transduction from receptor to
transcriptional targets, we mapped each transcriptionally altered
transcript on the WNT signaling map in Fig. 8. We depicted known
inhibitory relationships among molecules (either at the transcript
or protein level) by red lines and positive relationships by blue
lines. We also marked the genes with signiﬁcant transcriptional
changes identiﬁed in Sost /; Sostdc1 / E11.5 limb buds with a
red star for down-regulated genes or a green star for up-regulated
genes. Contrary to our hypothesis that both Sost and Sostdc1
interfere with canonical WNT signaling, we found β-catenin
(CTNNB1; Fig. 8; yellow box) transcript levels reduced by 5.27-
fold. In addition we found two inhibitors of canonical WNT
Table 1
Autopod phenotypic analysis of Sost and Sostdc1 single and double knockout mice.
Genotype Normal Syndactyly Ventral pigment Digit duplication
Sost / 95 4 1 0
Sostdc1 / 83 0 17 0
Sost /; Sostdc1 / 53 6 10a 36b
a 1 neonate had an extra dermal pad.
b 1 neonate had syndactyly; 4 had ventral pigmentation.
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Fig. 6. Altered SHH and FGF signaling causes polydactyly and syndactyly. Shh domain was expanded along the anterior–posterior and proximal–distal axis in Sost /and
Sost /; Sostdc1 / relative to WT and Sostdc1 / limb buds at E10.5 (A, arrows, bracket) and E11.5 (D). Downstream of Shh, Gli1 expression was dramatically expanded in
Sost /; Sostdc1 / E11.5 limb buds relative to all other genotypes (E, brackets). Grem1 expression was absent in Shh positive region, and in Sostdc1 / and Sost /;
Sostdc1 / limbs the Grem1 domain was reduced on the posterior side (B, brackets). Fgf8 AER expression domain was expanded and disorganized in Sost / and Sost /;
Sostdc1 / limbs, and on the anterior side of the Sost /; Sostdc1 / limbs Fgf8 expression was reduced in all time points examined (B and F–G, arrows). A reduction in
interdigital apoptosis was also detected on the anterior side of Sost /; Sostdc1 / limb buds at E12.5 (I, arrow).
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signaling: GSK3B and NLK to be signiﬁcantly up-regulated, 4.22-
and 3.51-fold, respectively; and hence to further contribute to
blunting β-catenin activator function, in the Sost /; Sostdc1 /
limbs. Immunoﬂuorescent stains of E12.5 sectioned limbs showed
a marked increase in both ectodermal and mesenchymal β-catenin
activity in Sost- / limbs, while Sostdc1 / limbs had a slight
reduction in mesenchyme. Consistent with the microarray expres-
sion data, the double knockouts exhibited a dramatic reduction in
both ectodermal and mesenchymal activated β-catenin (Fig. 9). In
addition, two known non-canonical WNT ligands, WNT5A and
WNT6 were signiﬁcantly up-regulated 2.86- and 2.23-folds,
respectively, and so were several transcription factors known to
activate downstream WNT targets, including TCF4, TCF12, Lef1,
and BCL9, along with several known WNT target genes, CCND, ID2
and FN1 (Table 2). While the microarray data conclusively high-
lighted WNT signaling as the only pathway signiﬁcantly up-
regulated, it also suggested that the phenotypes are driven by a
b-catenin independent mechanism, and likely facilitated by the
overabundance of the two non-canonical WNT ligands.
Discussion
The WNT signaling pathway is involved in a broad range of
developmental and physiological processes ranging from cell
proliferation, cell fate, body axis determination, tissue morpho-
genesis, and tissue homeostasis. Thus, its dysregulation has been
linked to multiple congenital and degenerative diseases, as well as
cancer. Sost and Sostdc1 have been previously described as WNT
antagonists, and therefore loss and/or gain-of-function mutations
in these molecules are likely to interfere with aspects of WNT
signaling pathway involved in critical developmental and
Table 2
Differentially expressed genes in the Sost; Sostdc1 KO E11.5 forelimb.
Up LogFC FC p-value Down LogFC FC p-value
WNT Tcf12 2.52 5.74 0.00020 Sfrp1 3.06 8.31 0.00024
signaling Id2 2.48 5.61 0.00008 Dvl2 2.93 7.61 0.00102
Fn1 2.41 5.34 0.00671 Fzd1 2.92 7.57 0.00038
Gsk3b 2.08 4.22 0.00039 Ror1 2.66 6.32 0.00230
Bcl9 1.93 3.82 0.00042 Ctnnb1 2.40 5.27 0.00015
Ccnd2 1.85 3.61 0.00512 Snai1 1.97 3.91 0.00004
Nlk 1.81 3.51 0.00055 Apc 1.91 3.75 0.00036
Lef1 1.72 3.29 0.01267 Frzb 1.84 3.57 0.00422
Wnt5a 1.52 2.86 0.01145 Fzd6 1.83 3.55 0.00022
Tcf4 1.35 2.56 0.00264 Csnk1d 1.77 3.40 0.00048
RhoA 1.33 2.51 0.00155 Axin2 1.65 3.15 0.00170
Wnt6 1.16 2.23 0.00010 Cdc42 1.62 3.07 0.00010
Csnk1a1 1.06 2.08 0.00400 Fzd7 1.48 2.79 0.00348
Tsc1 1.06 2.06 0.00187 Rac1 1.46 2.75 0.00004
Axin1 1.44 2.72 0.00025
Dkk3 1.12 2.16 0.00094
BMP signaling Twsg1 3.94 15.33 0.00171
Smad3 3.66 12.63 0.00022
Nog 2.47 5.56 0.00002
Bmp1 2.30 4.94 0.00017
Bmpr1b 2.05 4.14 0.00388
Bmp7 1.40 2.64 0.00101
Bmp2k 1.12 2.17 0.00715
Bmpr2 1.07 2.09 0.00832
FGF Fgf8 1.28 2.43 0.00453 Fgfr2 2.52 5.72 0.00007
signaling Fgfr1 2.31 4.95 0.00001
Fgfr3 1.51 2.84 0.00469
Homeobox Hoxa10 2.06 4.16 0.00675 Hoxd13 3.60 12.12 0.00006
transcription Hoxd4 1.93 3.80 0.00014 Tbx15 3.06 8.38 0.00061
factors Hoxc8 1.06 2.08 0.03535 Sox4 2.96 7.80 0.00230
Prrx1 2.64 6.23 0.00080
Hoxc5 2.39 5.25 0.00016
Hoxd12 2.11 4.33 0.00027
Sox6 1.95 3.85 0.00548
Sox5 1.50 2.83 0.00700
Hoxd11 1.36 2.56 0.00054
Pitx2 1.34 2.53 0.028202
Hoxc6 1.27 2.42 0.00275
Sox7 1.05 2.06 0.00024
SHH Shh 1.83 3.65 0.03943 Gli3 1.88 3.68 0.00352
signaling Ptch1 1.78 3.44 0.00635
Gli1 1.20 2.30 0.005846
TGFβ signaling Tgfbr1 4.75 27.03 0.00161
Smad3 3.66 12.63 0.00022
Tgfbr2 2.13 4.37 0.00108
Smurf2 1.67 3.18 0.0001
Tgfbr3 1.51 2.84 0.00085
Acvr1 1.48 2.79 0.003522
Smurf1 1.41 2.66 0.01048
Tgfb1 1.02 2.02 0.00096
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metabolic processes. Here we showed that both Sost and Sostdc1
have a broad tissue distribution in both the developing embryo
and the adult mouse, broadening our current understanding of
their expression pattern and therefore highlighting new potential
functional sites where these two molecules could interfere with
WNT and/or other signaling pathways. Their adjacent expression
domains in the developing limb show epithelial–mesenchymal
interactions that overlap to inﬂuence anterior digit patterning,
especially in that several genes do not appear to be differentially
regulated by in situ hybridization in single mutants, but show
altered expression only in Sost /; Sostdc1 / double mutants.
Second, we establish that the combined lack of Sost and Sostdc1
causes preaxial polydactyly through modulating SHH signaling,
through Gli3 transcriptional repression, up-regulation of Gli1 and
subsequent ectopic activation of Sox9 in the digit 1 ﬁeld. Ectopic
Sox9 expression in Sost /; Sostdc1 / mice is likely a conse-
quence of misregulated limb patterning genes upstream of Sox9,
since we show that patterning genes such as Grem1, Fgf8, and Shh
are misregulated in the developing limb of Sost /; Sostdc1 /
mice but they remain unaffected in Sox9 gain-of-function mutant
(Akiyama et al., 2007). The phenotype we describe herein is highly
similar to the recently described conditional inactivation of Gli3 in
the developing autopod using a Cre deletor under the control of
Hoxa13 locus (Lopez-Rios et al., 2012). In this study, Lopez-Rios
et al. were able to show that Gli3 acts in the anterior mesenchyme
to restrict and terminate Grem1 expression in the anterior autopod
in a spatiotemporally controlled manner, to promote BMP-
dependent exit of progenitors from the proliferation phase to the
chondrogenic differentiation stage. This is consistent with our data
that show increased Gli3 activation in the anterior limb restricts
Grem1 expression despite the lack of ectopic Shh. In the absence of
Gli3 repressor, chondrogenic differentiation is delayed, resulting in
an accumulation and subsequent increase in the pool of chondro-
genic progenitor cells, which ultimately create new digit ﬁelds in
the anterior region of the autopod (Lopez-Rios et al., 2012).
Lopez-Rios et al. show that the timing of Gli3 inactivation
determines the severity of the polydactyly phenotype, which in
turn is directly related to the duration of the proliferative expan-
sion of the progenitor cells phase, such that conditional inactiva-
tion of Gli3 using Hoxa13-Cre results in the dissipation of the Gli3
transcripts by E11.75, and subsequent duplication of digit 1 only
(Lopez-Rios et al., 2012). This timing coincides with the emergence
of Sostdc1 in the limb, since Sostdc1 expression initiates at E10.5 on
the ventral side of the autopod and subsequently expands to the
proximal region of the E11.5 autopod. The cumulative absence
of Sost and Sostdc1 from the developing limb represses Gli3
transcript levels by 3.68-fold which is sufﬁcient to generate a
phenotype highly similar to the removal of Gli3 allele at E11.5. As
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loss of Gli3 transcription results primarily in the loss of Gli3 rep-
ressor, our data shows that increased Gli3 activator without incre-
ased Gli3 transcription induces a similar mild preaxial polydactyly
phenotype, similar to a study that demonstrated a hypermorphic
allele of Gli3 increased the activator form of the protein and
resulted in mild preaxial polydactyly (Wang et al., 2007).
The SHH/GREM1/AER-FGF feedback loop has been studied
extensively and signiﬁcant evidence exists that indicate that BMP
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activity is at low levels during the proliferative expansion of digit
progenitors, but at higher levels during chondrogenic differentia-
tion (Bandyopadhyay et al., 2006; Lopez-Rios et al., 2012), and that
SHH modulates these downstream effects. In the present study, we
show that WNT signaling events upstream of SHH can produce
alterations in Gli3 expression which ultimately result in the same
chondrogenic differentiation defects that cause preaxial polydac-
tyly, positioning components of WNT signaling as novel candidates
for congenital malformations observed in patients with preaxial
polydactyly. Finally, extensive gene network and pathway analysis
revealed that the preaxial polydactyly phenotype observed in
Sost /; Sostdc1 / limbs, while consistent with a lack of WNT
inhibition molecular output, it is b-catenin independent, and likely
to be mediated by two non-canonical WNT ligands: Wnt5A and
Wnt6. In particular, since Wnt6 has been previously described as
an ectodermally derived negative regulator of chondrogenesis
(Geetha-Loganathan et al., 2010), the link between Sost, Sostdc1,
and Wnt6, chondrogenic differentiation and proliferation should
be further explored.
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